日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MVA-Spike encoding the A subunit of dmLT safely enhances systemic and mucosal immune responses

编码 dmLT A 亚基的 MVA-Spike 可安全地增强全身和黏膜免疫反应

Rambichler, Stephan; Kassub, Ronny; Carrasco-León, Rodrigo; Lämmermann, Kerstin; Feigl, Markus; Bathke, Barbara; Durand, Clémentine; Fras, Živa; Heiseke, Alexander; Riedl, André; Koppius, Andrea; Brod, Florian; Suter, Mark; Hausmann, Jürgen; Medina-Echeverz, José; Chaplin, Paul; Hochrein, Hubertus; Hinterberger, Maria

Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine

冻干制剂和液冻制剂的MVA-BN作为天花和痘疫苗的等效性

Greenberg, Richard N; Schmidt, Darja; Reichhardt, Daniela; Roesch, Siegfried; Vidojkovic, Sanja; Maclennan, Jane; Chen, Liddy M; Gruenert, Robert; Kreusel, Christian; Weidenthaler, Heinz; Meyer, Thomas P H; Chaplin, Paul John

A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection

一种基于重组MVA的RSV疫苗可诱导T细胞和抗体反应,二者协同作用以抵抗RSV感染。

Endt, Kathrin; Wollmann, Yvonne; Haug, Jana; Bernig, Constanze; Feigl, Markus; Heiseke, Alexander; Kalla, Markus; Hochrein, Hubertus; Suter, Mark; Chaplin, Paul; Volkmann, Ariane

Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memory

采用4-1BBL修饰的痘苗病毒安卡拉株进行瘤内病毒疗法,可根除实体瘤并促进保护性免疫记忆。

Hinterberger, Maria; Giessel, Raphael; Fiore, Giovanna; Graebnitz, Fabienne; Bathke, Barbara; Wennier, Sonia; Chaplin, Paul; Melero, Ignacio; Suter, Mark; Lauterbach, Henning; Berraondo, Pedro; Hochrein, Hubertus; Medina-Echeverz, José

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

一种经MVA加强的单价黑猩猩腺病毒埃博拉疫苗

Ewer, Katie; Rampling, Tommy; Venkatraman, Navin; Bowyer, Georgina; Wright, Danny; Lambe, Teresa; Imoukhuede, Egeruan B; Payne, Ruth; Fehling, Sarah Katharina; Strecker, Thomas; Biedenkopf, Nadine; Krähling, Verena; Tully, Claire M; Edwards, Nick J; Bentley, Emma M; Samuel, Dhanraj; Labbé, Geneviève; Jin, Jing; Gibani, Malick; Minhinnick, Alice; Wilkie, Morven; Poulton, Ian; Lella, Natalie; Roberts, Rachel; Hartnell, Felicity; Bliss, Carly; Sierra-Davidson, Kailan; Powlson, Jonathan; Berrie, Eleanor; Tedder, Richard; Roman, Francois; De Ryck, Iris; Nicosia, Alfredo; Sullivan, Nancy J; Stanley, Daphne A; Mbaya, Olivier T; Ledgerwood, Julie E; Schwartz, Richard M; Siani, Loredana; Colloca, Stefano; Folgori, Antonella; Di Marco, Stefania; Cortese, Riccardo; Wright, Edward; Becker, Stephan; Graham, Barney S; Koup, Richard A; Levine, Myron M; Volkmann, Ariane; Chaplin, Paul; Pollard, Andrew J; Draper, Simon J; Ballou, W Ripley; Lawrie, Alison; Gilbert, Sarah C; Hill, Adrian V S

A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis

一项多中心、开放标签、对照的II期研究,旨在评估MVA天花疫苗(IMVAMUNE)在18-40岁确诊特应性皮炎受试者中的安全性和免疫原性。

Greenberg, Richard N; Hurley, Maria Yadira; Dinh, Dinh V; Mraz, Serena; Vera, Javier Gomez; von Bredow, Dorothea; von Krempelhuber, Alfred; Roesch, Siegfried; Virgin, Garth; Arndtz-Wiedemann, Nathaly; Meyer, Thomas Peter; Schmidt, Darja; Nichols, Richard; Young, Philip; Chaplin, Paul

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects

比较冻干型与液体型改良痘苗病毒安卡拉株(MVA)制剂以及皮下注射与皮内注射途径在健康未接种过痘苗病毒的受试者中的疗效

Frey, Sharon E; Wald, Anna; Edupuganti, Srilatha; Jackson, Lisa A; Stapleton, Jack T; El Sahly, Hana; El-Kamary, Samer S; Edwards, Kathryn; Keyserling, Harry; Winokur, Patricia; Keitel, Wendy; Hill, Heather; Goll, Johannes B; Anderson, Edwin L; Graham, Irene L; Johnston, Christine; Mulligan, Mark; Rouphael, Nadine; Atmar, Robert; Patel, Shital; Chen, Wilbur; Kotloff, Karen; Creech, C Buddy; Chaplin, Paul; Belshe, Robert B

Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responses

重组改良痘苗病毒安卡拉株产生过量的早期双链RNA,可瞬时激活蛋白激酶R,并触发增强的先天免疫反应。

Wolferstätter, Michael; Schweneker, Marc; Späth, Michaela; Lukassen, Susanne; Klingenberg, Marieken; Brinkmann, Kay; Wielert, Ursula; Lauterbach, Henning; Hochrein, Hubertus; Chaplin, Paul; Suter, Mark; Hausmann, Jürgen

Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario

采用不同策略评估 IMVAMUNE® 天花疫苗在事件后情景下的安全性和免疫原性

Frey, Sharon E; Winokur, Patricia L; Salata, Robert A; El-Kamary, Samer S; Turley, Christine B; Walter, Emmanuel B Jr; Hay, Christine Mhorag; Newman, Frances K; Hill, Heather R; Zhang, Ying; Chaplin, Paul; Tary-Lehmann, Magdalena; Belshe, Robert B

A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr).

使用重组改良痘苗病毒安卡拉株 (MVA-hTyr) 对 II 期黑色素瘤患者进行酪氨酸酶 I 期疫苗接种研究

Meyer Ralf G, Britten Cedrik M, Siepmann Ulrike, Petzold Barbara, Sagban Tolga A, Lehr Hans A, Weigle Bernd, Schmitz Marc, Mateo Luis, Schmidt Burkhard, Bernhard Helga, Jakob Thilo, Hein Rüdiger, Schuler Gerold, Schuler-Thurner Beatrice, Wagner Stephan N, Drexler Ingo, Sutter Gerd, Arndtz Nathaly, Chaplin Paul, Metz Jost, Enk Alexander, Huber Christoph, Wölfel Thomas